Table 1.
Recombinant Human Apolipoprotein Purification Protocol
| Step | Parameter | Value | Description |
|---|---|---|---|
| 1 | Centrifugation | 15,000 rpm, 10 min | |
| 2 | Dilution | 4 times | 20 mM NaAc–HAc buffer |
| 3 | Adjusted pH | 3.0 | HAc |
| 4 | Cation exchange chromatography | 0.5 mL/min | To bind rhApoA-II |
| 5 | Elution | 1 mL/min | A linear gradient of NaCl |
| 6 | Collected eluted proteins | Analysis of eluted proteins | |
| 7 | Reverse phase chromatography | 0.5 mL/min | Desalination and further purification |
| 8 | Elution | 1 mL/min | Methanol |
| 9 | Collected eluted proteins | Analysis of eluted proteins | |
| 10 | Remove D methanol | Vacuum distillation and freeze drying |
Step Notes
1. Collected supernatant form fermentation broth.
2. The supernatant was diluted four times with 20 mM NaAc–HAc (pH 3.0) buffer.
3. The pH of the supernatant was adjusted to 3.0 with 1 M acetate acid.
4. The supernatant was loaded onto the cation exchange chromatographic column at the rate of 0.5 mL/min.
5. The bound protein was eluted with a linear gradient of 0.1–1.0 M NaCl, while the flow rate was maintained at the rate of 1 mL/min.
6. Protein elution was monitored by measuring the absorbance at 280 nm and SDS-PAGE analysis.
7. Column eluent containing rhApoA-II was loaded onto a reverse phase column, which was equilibrated with 0.1% TFA, for the further purification.
8. RhApoA-II was eluted using 50% and 100% methanol (containing 0.1% TFA) at the rate of 1 mL/min.
9. Protein elution was monitored by measuring the absorbance at 280 nm and SDS-PAGE analysis.
10. RhApoA-II was concentrated by vacuum distillation and freeze drying to remove methanol.
rhApoA-II, recombinant human apolipoprotein A-II; TFA, trifluoroacetic acid; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis.